Amyloid deposition involves abnormal protein buildup in tissues, often linked to diseases like Alzheimer’s and amyloidosis. It serves as a key biomarker for diagnosing these conditions, helping doctors monitor progression. Patients with neurodegenerative or systemic amyloid disorders benefit most from early detection through imaging or biopsies, enabling timely treatment and improved outcomes.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends